Moderated by the Chair of the National Science Advisory Board for Biosecurity (NSABB), Paul Keim, Ph.D., this newly added session at the ASM Biodefense and Emerging Diseases Research Meeting will include discussions of the NSABB’s recommendations for the publication of the controversial H5N1 research. This session will also provide an open forum for those attending the conference to give their feedback on such policy issues as the appropriate mechanisms to allay public concerns about the safety of dual use research.

Viewing Details
The link to access the live stream will be posted to www.asmbiodefense.org the morning of the session, Wednesday, February 29th. If you are unable to view the live streamed session, archived footage will be available starting at 1 p.m. the same day.

Discussion of NSABB’s publication recommendations for the NIH-funded research on the transmissibility of H5N1

Presentations will include:

NSABB Recommendations
Michael T. Osterholm, Ph.D., MPH
University of Minnesota School of Public Health, Minneapolis, MN
Director, Center for Infectious Disease Research and Policy (CIDRAP)

Government Response to the Recommendations
Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases (NIAID)

Science’s Response to the Situation
Bruce Alberts, Ph.D.
Editor-in-Chief of Science

Perspective from an Investigator
Ron A.M. Fouchier, Ph.D.
Erasmus MC, Rotterdam, Netherlands

For details on other sessions being held at the 10th ASM Biodefense and Emerging Diseases Research Meeting, please visit www.asmbiodefense.org.